首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Cpt-pharmacometrics & Systems Pharmacology

Cpt-pharmacometrics & Systems Pharmacology杂志,由WILEY出版,12 issues/year,出版语言English,ISSN:2163-8306,E-ISSN:2163-8306。

投稿咨询
Cpt-pharmacometrics & Systems Pharmacology
Cpt-pharmacometrics & Systems Pharmacology
Cpt-pharmacometrics & Systems Pharmacology
SCI SCIE

杂志介绍

JCR分区
Q3
中科院分区
3区
影响因子
2.8
CiteScore
5.1
期刊收录
SCI、SCIE

Cpt-pharmacometrics & Systems Pharmacology(中文译名:《Cpt-药理学和系统药理学》),ISSN:2163-8306,EISSN:2163-8306,是WILEY出版的国际性学术期刊,以12 issues/year形式稳定发行,2026年总发文量约181篇。该刊采用OA开放访问,学科归属为PHARMACOLOGY & PHARMACY。该刊是医学、药学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达2.8,2025年期刊CiteScore为5.1,2025年期刊自引率约10.7%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Cpt-pharmacometrics & Systems Pharmacology长期聚焦医学、药学及相关产业的技术应用前沿,平均审稿周期8 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、药学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAEngland、GERMANY (FED REP GER)、Netherlands、Sweden、France、Switzerland等为核心发文国家与地区;ASTRAZENECAPFIZER、US FOOD & DRUG ADMINISTRATION (FDA)、ROCHE HOLDING、LEIDEN UNIVERSITY、NOVARTIS、GLAXOSMITHKLINE等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
PHARMACOLOGY & PHARMACY 药学
3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q3 181 / 356

49.3

学科:PHARMACOLOGY & PHARMACY SCIE Q2 117 / 356

67.28

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:PHARMACOLOGY & PHARMACY SCIE Q2 126 / 354

64.5

学科:PHARMACOLOGY & PHARMACY SCIE Q2 92 / 354

74.15


中国学者近期发文

1
Integrative QSP Modeling of Cancer Stem Cells in Triple-Negative Breast Cancer: Impacts on Tumor Immunity and Response to Immune Checkpoint Inhibitor

Author:Xue, Junsheng; Jian, Weizhe; Wang, Tianyu; Jiang, Zhujun; Hou, Xinyu; Yang, Qirui; Bao, Tianyu; Cai, Lei; Gan, Enze; Liu, Chen; Zhou, Tianyan

Journal: CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY. 2026; Vol. 15, Issue 4, pp. -. DOI: 10.1002/psp4.70245

2
Population Pharmacokinetics of Serplulimab and Quantitative Assessment of Transitioning From Weight-Based to Flat-Dosing Strateg

Author:Wang, Kun; Shen, Yuanyuan; Hu, Chen; Xu, Fengyan; Kwok, Zhihao; Wang, Qingyu; Lin, Yaqi; Gao, Yuying; Zhou, Liang

Journal: CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY. 2026; Vol. 15, Issue 4, pp. -. DOI: 10.1002/psp4.70204

3
Unraveling the Link Between Azathioprine and Acute Pancreatitis: Integrating Network Toxicology, Machine Learning, and Mendelian Randomizatio

Author:Xie, Zhijun; Lei, Hang; Zhang, Pengcheng; Li, Zhi; Tang, Wenfu

Journal: CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/psp4.70178

4
Model-Informed Dosing Regimen of Sugemalimab for European Patients With Non-Small Cell Lung Cancer: Bridging From Asian Clinical Dat

Author:Sheng, Yucheng; Yue, Zenglian; Xu, Fengyan; Wang, Kun; Wang, Jingru; Shi, Qingmei

Journal: CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY. 2026; Vol. 15, Issue 3, pp. -. DOI: 10.1002/psp4.70220

5
Quantitative Evaluation of Model-Informed Drug Development Implementation in China's Approved Innovative Drugs: From Policy to Practice (2018-2024

Author:Li, Jian; Wang, Zhenlei; Wei, Chunmin; He, Ruirui; Yao, Qingyu

Journal: CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY. 2026; Vol. 15, Issue 2, pp. -. DOI: 10.1002/psp4.70211

6
Examining the Reliability of Model-Based Meta-Analysis (MBMA) Outcomes: A Simulation Stud

Author:Yu, Jiesen; Li, Ting; Luo, Jieren; Zheng, Qingshan; Li, Lujin

Journal: CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/psp4.70053

7
Population Pharmacokinetics and Exposure-Response Relationship of Hemoporfin in Pediatric Patients With Port-Wine Stai

Author:Chen, Rong; Zhang, Bin; Tao, Jining; Yao, Qingyu; Zhou, Tianyan; Ma, Lin; Xu, Zigang

Journal: CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/psp4.70050

8
Development and Verification of a Physiologically Based Pharmacokinetic Model of Furmonertinib and Its Main Metabolite for Drug-Drug Interaction Prediction

Author:Wu, Yali; Loer, Helena Leonie Hanae; Zhang, Yifan; Zhong, Dafang; Jiang, Yong; Hu, Jie; Fuhr, Uwe; Lehr, Thorsten; Diao, Xingxing

Journal: CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/psp4.70052

9
Push Forward Clinical Management of Hematological Toxicity due to Lenalidomide Overexposure: Model-Informed Precision Dosing for Chinese Population With Renal Insufficienc

Author:Ma, Yi; Song, Zaiwei; Bing, Hao; He, Huan; Zhao, Libo; Zhao, Rongsheng

Journal: CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/psp4.70040

10
Elucidating Contributions of Drug Transporters/Enzyme to Nonlinear Pharmacokinetics of Grazoprevir by PBPK Modeling With a Cluster Gauss-Newton Metho

Author:Yoshikado, Takashi; Aoki, Yasunori; Nakamura, Ryo; Shida, Saeko; Sugiyama, Yuichi; Chiba, Koji

Journal: CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY. 2025; Vol. , Issue , pp. -. DOI: 10.1002/psp4.13314


在线咨询

Cpt-pharmacometrics & Systems Pharmacology

国际简称:CPT-PHARMACOMET SYST参考译名:Cpt-药理学和系统药理学

年发文量:181 CiteScore:5.1 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:93.92%

杂志社联系方式:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774

Cpt-pharmacometrics & Systems Pharmacology